Global Oxytocic Pharmaceuticals Market Study Covering Size, Share, Growth, Trends and Upcoming Opportunities, 2016-2026

An up-to-date research report has been disclosed by MRRSE highlighting the titled “Global Oxytocic Pharmaceuticals Market Study Covering Size, Share, Growth, Trends and Upcoming Opportunities, 2016-2026” which provides an outlook of current market value as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR of 11.7% during 2016-2026. The report studies the Oxytocic Pharmaceuticals Market worldwide, especially in North America, Europe, Southeast Asia, India and Other Regions with production, size, growth, revenue, consumption, import and export in these regions.

Sample report is available here – https://www.mrrse.com/sample/2940

The post-partum haemorrhage segment was estimated to account for more than 75% market share of the global oxytocic pharmaceuticals market by the end of 2016 and is expected to gain more than 200 BPS in its market share by 2026. The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period. The post-partum haemorrhage segment is estimated to create absolute $ opportunity of more than US$ 5 Mn in 2017 over 2016. This segment dominated the global oxytocic pharmaceuticals market in terms of revenue in 2015, and the trend is projected to continue throughout the period of forecast.

Labour induction during childbirth is likely to boost the post-partum haemorrhage segment

Increasing childbirth using labour induction proves to be driving factor for the post-partum haemorrhage condition. There are certain situations – for instance, pre-eclampsia – where continuing the pregnancy is dangerous to the mother, or there are instances where women are uncomfortable, sore and tired. In such cases, labour is induced for convenience rather than medical reasons. However, labour induction increases the chances of post-partum haemorrhage. According to the World Health Organization, the rate of labour induction in developing countries is lower; but in developed countries, the rates are relatively high, which is creating a positive impact on the post-partum haemorrhage segment. Another factor which is likely to fuel the revenue growth of the post-partum haemorrhage segment is the increasing age of mothers. Older and heavier women and women who are smokers are more likely to bleed heavily after delivery. The ratio of getting pregnant after a certain age in life has increased in almost all the regions across the globe and this is creating robust development in the global oxytocic pharmaceuticals market, and specifically in the post-partum haemorrhage segment.

Browse full report in-depth here – https://www.mrrse.com/oxytocic-pharmaceuticals-industry

The post-partum haemorrhage segment is the most attractive segment by indication in the North America oxytocic pharmaceuticals market, with a market attractiveness index of 3.9 estimated during the forecast period. In the Latin America region, the post-partum haemorrhage segment is estimated to reach a market attractiveness index of 3.7 due to increasing adolescent pregnancies. A majority of these pregnancies occur in Brazil in Latin America. An increase in labour induction procedures in the region is responsible for positioning post-partum haemorrhage as the most attractive indication segment.

The MEA region represents a higher prevalence of post-partum haemorrhage among all the regions owing to lack of proper nutrition to pregnant women. Africa’s contribution to the prevalence of post-partum haemorrhage in the MEA region is on the higher end, owing to a lack of healthcare infrastructure and awareness regarding pregnancy related aspects among African women. Prevalence of post-partum haemorrhage is as high as 25.7% in African countries and 8.5% in Asian countries. In China, the post-partum haemorrhage segment is anticipated to record a market attractiveness index of 3.8 during the forecast period. A large pool of population and China’s altered single child policy to two children policy may likely increase the incidence of post-partum haemorrhage.

The forecast presented in our report on the global oxytocic pharmaceuticals market assesses the total revenue generated in the global oxytocic pharmaceuticals market. When developing the forecast, the starting point involves sizing the current market, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the characteristics of the market, we have triangulated the outcome based on an analysis of supply side and demand side dynamics. For quantifying market numbers, we have conducted interviews with subject matter experts in the global oxytocic pharmaceuticals market.

Ask anything about this report by using an enquiry form here - https://www.mrrse.com/enquiry/2940

Companies functioning in the global oxytocic pharmaceuticals market can reap larger market revenue from untapped markets in Asia and Africa where the prevalence of post-partum haemorrhage is on the higher side in comparison with other regions. Imparting awareness pertaining to pregnancy among the women in these regions can help create more market opportunities for existing as well as new entrants in the global oxytocic pharmaceuticals market.

MRRSE Overview

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Details:

State Tower

90, State Street, Suite 700

Albany, NY – 12207 (United States)

Telephone: +1-518-730-0559

Email: sales@mrrse.com

Website: https://www.mrrse.com/

Read More Industry News At: https://www.industrynewsanalysis.com/

This release was published on openPR.